Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision tag v3.5.4 was added and the previous revision v3.5.3 was removed.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision has been updated from v3.5.2 to v3.5.3, indicating a new version of the page. The underlying study information and content remain the same.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Revision: v3.5.0; Deleted Revision: v3.4.3.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This appears to be a software/version bump with no visible changes to study content or user-facing features.SummaryDifference0.0%

- Check112 days agoChange DetectedThe page now shows a minor site revision label 'Revision: v3.4.2' and removes the prior 'Revision: v3.4.1' label, including a government funding status notice.SummaryDifference0.2%

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.